T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

NCT02326974 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

164

Enrollment

OTHER

Sponsor class

Conditions

HER-2 Positive Breast Cancer
Breast Cancer
Stage II Breast Cancer
Stage III Breast Cancer

Interventions

DRUG: T-DM1
DRUG: Pertuzumab
PROCEDURE: Excision of tumor/mastectomy

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]